These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1551864)

  • 1. Aggregation and organization of pardaxin in phospholipid membranes. A fluorescence energy transfer study.
    Rapaport D; Shai Y
    J Biol Chem; 1992 Apr; 267(10):6502-9. PubMed ID: 1551864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers.
    Rapaport D; Shai Y
    J Biol Chem; 1991 Dec; 266(35):23769-75. PubMed ID: 1748653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pardaxin: channel formation by a shark repellant peptide from fish.
    Shai Y
    Toxicology; 1994 Feb; 87(1-3):109-29. PubMed ID: 8160183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH- and ionic strength-dependent fusion of phospholipid vesicles induced by pardaxin analogues or by mixtures of charge-reversed peptides.
    Rapaport D; Hague GR; Pouny Y; Shai Y
    Biochemistry; 1993 Apr; 32(13):3291-7. PubMed ID: 8461295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.
    Oren Z; Shai Y
    Eur J Biochem; 1996 Apr; 237(1):303-10. PubMed ID: 8620888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-dependent pore formation properties of pardaxin analogues.
    Shai Y; Hadari YR; Finkels A
    J Biol Chem; 1991 Nov; 266(33):22346-54. PubMed ID: 1939258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible surface aggregation in pore formation by pardaxin.
    Rapaport D; Peled R; Nir S; Shai Y
    Biophys J; 1996 Jun; 70(6):2502-12. PubMed ID: 8744290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of D-amino acid incorporated analogues of pardaxin with membranes.
    Pouny Y; Shai Y
    Biochemistry; 1992 Oct; 31(39):9482-90. PubMed ID: 1390731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Channel formation properties of synthetic pardaxin and analogues.
    Shai Y; Bach D; Yanovsky A
    J Biol Chem; 1990 Nov; 265(33):20202-9. PubMed ID: 1700783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and activity studies of pardaxin and analogues using model membranes of phosphatidylcholine.
    Barrow CJ; Nakanishi K; Tachibana K
    Biochim Biophys Acta; 1992 Dec; 1112(2):235-40. PubMed ID: 1457455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of action of the antibacterial cecropin B2: a spectrofluorometric study.
    Gazit E; Lee WJ; Brey PT; Shai Y
    Biochemistry; 1994 Sep; 33(35):10681-92. PubMed ID: 8075068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol reduces pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investigated by solid-state NMR.
    Ramamoorthy A; Lee DK; Narasimhaswamy T; Nanga RP
    Biochim Biophys Acta; 2010 Feb; 1798(2):223-7. PubMed ID: 19716800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of hydrophobic peptides with model membranes: slow binding to membranes and not subtle variations in pore structure is responsible for the gradual release of entrapped solutes.
    Saberwal G; Nagaraj R
    Biochim Biophys Acta; 1993 Sep; 1151(1):43-50. PubMed ID: 8357819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pardaxin induces aggregation but not fusion of phosphatidylserine vesicles.
    Lelkes PI; Lazarovici P
    FEBS Lett; 1988 Mar; 230(1-2):131-6. PubMed ID: 2450781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic peptide corresponding to the hydrophobic amino terminal region of pardaxin can perturb model membranes of phosphatidyl choline and serine.
    Saberwal G; Nagaraj R
    Biochim Biophys Acta; 1989 Sep; 984(3):360-4. PubMed ID: 2775781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capacities of pardaxin analogues to induce fusion and leakage of negatively charged phospholipid vesicles are not necessarily correlated.
    Rapaport D; Nir S; Shai Y
    Biochemistry; 1994 Oct; 33(42):12615-24. PubMed ID: 7918487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orientation and aggregation of hydrophobic helical peptides in phospholipid bilayer membrane.
    Otoda K; Kimura S; Imanishi Y
    Biochim Biophys Acta; 1993 Jul; 1150(1):1-8. PubMed ID: 8334135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Crucial Residues in the Early Insertion of Pardaxin into Different Phospholipid Bilayers.
    Jafari M; Mehrnejad F; Aghdami R; Chaparzadeh N; Razaghi Moghadam Kashani Z; Doustdar F
    J Chem Inf Model; 2017 Apr; 57(4):929-941. PubMed ID: 28301157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization, membrane interaction, and specific assembly within phospholipid membranes of hydrophobic segments from Bacillus thuringiensis var. israelensis cytolytic toxin.
    Gazit E; Shai Y
    Biochemistry; 1993 Nov; 32(46):12363-71. PubMed ID: 8241124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism and kinetics of delta-lysin interaction with phospholipid vesicles.
    Pokorny A; Birkbeck TH; Almeida PF
    Biochemistry; 2002 Sep; 41(36):11044-56. PubMed ID: 12206677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.